April 24th 2025, 8:00pm
CURE spoke with John Crispino, the director of the division of experimental hematology at St. Jude Children’s Research Hospital.
April 24th 2025, 7:00pm
The first patient has been enrolled in the ARID II trial evaluating Voro Urologic Scaffold to improve continence after prostate cancer surgery.
April 24th 2025, 5:00pm
After a long battle with illness and seeking many specialists, I emphasize the need to self-advocate for ongoing care following my cancer diagnosis.
April 24th 2025, 3:58pm
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma.
April 24th 2025, 3:00pm
In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation period was successfully completed.
April 24th 2025, 1:00pm
In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing research to improve patient outcomes.
April 23rd 2025, 9:00pm
Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.
April 23rd 2025, 8:00pm
Dr. Douglas Reznick shares advice for patients with lung or head and neck cancer who may feel overwhelmed by their diagnosis.
April 23rd 2025, 7:00pm
A push for answers led to a rare blood disorder diagnosis after Joy’s symptoms were initially dismissed.
April 23rd 2025, 5:00pm
As spring arrives, I embrace the season’s renewal, reflecting on my journey with cancer and the freedom I’ll feel when I stop my treatment. Life is a gift.
Finally Learning to Put Myself First
Experts Discuss Next Steps in Perioperative Bladder Cancer Treatment
Signatera Guides Bladder Cancer Treatment After Surgery
What If? Embracing Hope During a Cancer Journey